X4 Pharmaceuticals announced the acceptance of two abstracts for presentation at the upcoming European Hematology Association Congress regarding the positive results from their Phase 2 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback